Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging pharmacotherapy for inflammatory bowel diseases
Hua Luo, Guiqing Cao, Chun Luo, et al.
Pharmacological Research (2022) Vol. 178, pp. 106146-106146
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 897-897
Open Access | Times Cited: 79
Improved colonic inflammation by nervonic acid via inhibition of NF-κB signaling pathway of DSS-induced colitis mice
Shengnan Yuan, Mu-xuan Wang, Jinlong Han, et al.
Phytomedicine (2023) Vol. 112, pp. 154702-154702
Open Access | Times Cited: 36
Recent progress on engineered micro/nanomaterials mediated modulation of gut microbiota for treating inflammatory bowel disease
Lingling Kan, Ziwen Zheng, Wanyue Fu, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 43-65
Closed Access | Times Cited: 12
Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment
Xue‐Chun Fang, Junjie Feng, Xingcheng Zhu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 890-909
Closed Access | Times Cited: 10
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis
Xu-Dong Tang, Yangyang Shang, Hong Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Stimulus-Responsive Drug Delivery Nanoplatforms for Inflammatory Bowel Disease Therapy
Long Jiang, Xiaoya Liang, Zuojin Ao, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 9
Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice
Xiaodong Li, Xia Wu, Qi Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154321-154321
Closed Access | Times Cited: 37
Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
John Gubatan, Theresa Louise Boye, Michelle Temby, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1371-1371
Open Access | Times Cited: 31
A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging
Haidi Guan, Zhongwei Xu, Guangsheng Du, et al.
Materials Today Bio (2023) Vol. 19, pp. 100610-100610
Open Access | Times Cited: 20
Research progress of colon-targeted oral hydrogel system based on natural polysaccharides
Dingding Wang, Weibo Wang, Ping Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123222-123222
Closed Access | Times Cited: 20
The single-cell modification strategies for probiotics delivery in inflammatory bowel disease: A review
Mengzhen Han, Wenzhi Lei, Jingjing Liang, et al.
Carbohydrate Polymers (2023) Vol. 324, pp. 121472-121472
Closed Access | Times Cited: 18
Characteristics and associated factors of health information-seeking behaviour among patients with inflammatory bowel disease in the digital era: a scoping review
Zijun Ni, Lingli Zhu, Shuyan Li, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei, Mingxing Li, Qin Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3307-3334
Open Access | Times Cited: 7
Synbiotics containing sea buckthorn polysaccharides ameliorate DSS-induced colitis in mice via regulating Th17/Treg homeostasis through intestinal microbiota and their production of BA metabolites and SCFAs
Mingyou Yuan, Lili Chang, Pan Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133794-133794
Closed Access | Times Cited: 7
Qing-Chang-Hua-Shi granule ameliorates DSS-induced colitis by activating NLRP6 signaling and regulating Th17/Treg balance
Cheng Cheng, Jingyi Hu, Yanan Li, et al.
Phytomedicine (2022) Vol. 107, pp. 154452-154452
Open Access | Times Cited: 25
Probiotics, their action modality and the use of multi-omics in metamorphosis of commensal microbiota into target-based probiotics
Maryam Idrees, Muhammad Imran, Naima Atiq, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 23
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances
Shumeng Hu, Runan Zhao, Yu Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 1, pp. 13-38
Closed Access | Times Cited: 13
Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice
Shengjie Li, Aoxiang Zhuge, Hui Chen, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Cytokine Profile in Predicting the Effectiveness of Advanced Therapy for Ulcerative Colitis: A Narrative Review
Hiroki Kurumi, Yoshihiro Yokoyama, Takehiro Hirano, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 952-952
Open Access | Times Cited: 5
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Ginseng exosomes modulate M1/M2 polarisation by activating autophagy and target IKK/IкB/NF-кB to alleviate inflammatory bowel disease
Song Yang, Liangliang Fan, Lijia Yin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
3-Fucosyllactose alleviates DSS-induced mouse colitis through modulation of the PI3K-Akt signaling pathway: An integrated multi-omics analysis
Qian Hao, Xutong Li, Mingzhu Mu, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106789-106789
Open Access
Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review
Pengyu Lei, Haiyang Yu, Jiahui Ma, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 126000-126000
Closed Access | Times Cited: 12
Limosilactobacillus fermentum HF06‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis
Chunhong Liu, Xiaofen Qi, Dan Li, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 104, Iss. 3, pp. 1702-1712
Closed Access | Times Cited: 12
Traditional herbal pair Portulacae Herba and Granati Pericarpium alleviates DSS-induced colitis in mice through IL-6/STAT3/SOCS3 pathway
Zhe Cheng, Yi Zhou, Xinyu Xiong, et al.
Phytomedicine (2023) Vol. 126, pp. 155283-155283
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top